Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis.
Saved in:
| Title: | Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. |
|---|---|
| Authors: | Jung HR; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea., Lee J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Hong SP; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin N; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Cho A; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin DJ; Medicine Major, Seoul National University College of Medicine, Seoul, Republic of Korea., Choi JW; College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea., Kim JI; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Lee JP; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. nephrolee@gmail.com.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. nephrolee@gmail.com., Cho SY; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr. |
| Source: | Experimental & molecular medicine [Exp Mol Med] 2024 Feb; Vol. 56 (2), pp. 355-369. Date of Electronic Publication: 2024 Feb 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
